Switch theme
Sign up to access all valuation multiples
Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue from the DACH segment, which represents income generated from Germany, Austria, and Switzerland. The International segment represents its income generated from Belgium, the Netherlands, France, and Italy.
2015
2.7K+
LTM Revenue $3.0B
LTM EBITDA $51.7M
$2.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Redcare Pharmacy has a last 12-month revenue (LTM) of $3.0B and a last 12-month EBITDA of $51.7M.
In the most recent fiscal year, Redcare Pharmacy achieved revenue of $2.7B and an EBITDA of $31.6M.
Redcare Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Redcare Pharmacy valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.0B | XXX | $2.7B | XXX | XXX | XXX |
| Gross Profit | $682M | XXX | $613M | XXX | XXX | XXX |
| Gross Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $51.7M | XXX | $31.6M | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 1% | XXX | XXX | XXX |
| EBIT | -$29.3M | XXX | -$43.8M | XXX | XXX | XXX |
| EBIT Margin | -1% | XXX | -2% | XXX | XXX | XXX |
| Net Profit | -$40.8M | XXX | -$51.1M | XXX | XXX | XXX |
| Net Margin | -1% | XXX | -2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $129M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Redcare Pharmacy's stock price is EUR 118 (or $132).
Redcare Pharmacy has current market cap of EUR 2.4B (or $2.7B), and EV of EUR 2.4B (or $2.7B).
See Redcare Pharmacy trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.7B | $2.7B | XXX | XXX | XXX | XXX | $-1.92 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Redcare Pharmacy has market cap of $2.7B and EV of $2.7B.
Redcare Pharmacy's trades at 1.0x EV/Revenue multiple, and 86.2x EV/EBITDA.
Equity research analysts estimate Redcare Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Redcare Pharmacy has a P/E ratio of -65.2x.
See valuation multiples for Redcare Pharmacy and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.7B | XXX | $2.7B | XXX | XXX | XXX |
| EV (current) | $2.7B | XXX | $2.7B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 52.8x | XXX | 86.2x | XXX | XXX | XXX |
| EV/EBIT | -93.2x | XXX | -62.3x | XXX | XXX | XXX |
| EV/Gross Profit | 4.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -65.2x | XXX | -52.1x | XXX | XXX | XXX |
| EV/FCF | -206.5x | XXX | -121.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialRedcare Pharmacy's last 12 month revenue growth is 24%
Redcare Pharmacy's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.2M for the same period.
Redcare Pharmacy's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Redcare Pharmacy's rule of X is 61% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Redcare Pharmacy and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | 93% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | 26% | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 61% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.0M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Redcare Pharmacy acquired XXX companies to date.
Last acquisition by Redcare Pharmacy was XXXXXXXX, XXXXX XXXXX XXXXXX . Redcare Pharmacy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Redcare Pharmacy founded? | Redcare Pharmacy was founded in 2015. |
| Where is Redcare Pharmacy headquartered? | Redcare Pharmacy is headquartered in Germany. |
| How many employees does Redcare Pharmacy have? | As of today, Redcare Pharmacy has 2.7K+ employees. |
| Is Redcare Pharmacy publicy listed? | Yes, Redcare Pharmacy is a public company listed on FRA. |
| What is the stock symbol of Redcare Pharmacy? | Redcare Pharmacy trades under RDC ticker. |
| When did Redcare Pharmacy go public? | Redcare Pharmacy went public in 2016. |
| Who are competitors of Redcare Pharmacy? | Similar companies to Redcare Pharmacy include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Redcare Pharmacy? | Redcare Pharmacy's current market cap is $2.7B |
| What is the current revenue of Redcare Pharmacy? | Redcare Pharmacy's last 12 months revenue is $3.0B. |
| What is the current revenue growth of Redcare Pharmacy? | Redcare Pharmacy revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Redcare Pharmacy? | Current revenue multiple of Redcare Pharmacy is 0.9x. |
| Is Redcare Pharmacy profitable? | Yes, Redcare Pharmacy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Redcare Pharmacy? | Redcare Pharmacy's last 12 months EBITDA is $51.7M. |
| What is Redcare Pharmacy's EBITDA margin? | Redcare Pharmacy's last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of Redcare Pharmacy? | Current EBITDA multiple of Redcare Pharmacy is 52.8x. |
| What is the current FCF of Redcare Pharmacy? | Redcare Pharmacy's last 12 months FCF is -$13.2M. |
| What is Redcare Pharmacy's FCF margin? | Redcare Pharmacy's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Redcare Pharmacy? | Current FCF multiple of Redcare Pharmacy is -206.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
